|
Federal Register
Notices > Importers Notice of Application 2009
> Lipomed, Inc.
FR Doc E9-15445[Federal Register: June 30, 2009 (Volume 74, Number 124)]
[Notices] [Page 31312-31313] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30jn09-97]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated April 1, 2009, and published in the Federal Register on April
9, 2009, (74 FR 16234), Lipomed, Inc., One Broadway, Cambridge, Massachusetts
02142, made application by renewal to the Drug Enforcement Administration (DEA)
to be registered as an importer of the basic classes of controlled substances
listed in schedules I and II:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| Fenethylline (1503) |
I |
| Methaqualone (2565) |
I |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Lysergic acid diethylamide (7315) |
I |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) |
I |
| Marihuana (7360) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine (7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine (7399) |
I |
| 3,4-Methylenedioxyamphetamine (7400) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
| 3,4-Methylenedioxymethamphetamine (7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| Dimethyltryptamine (7435) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| N-Benzylpiperazine (7493) |
I |
| Acetyldihydrocodeine (9051) |
I |
| Dihydromorphine (9145) |
I |
| Heroin (9200) |
I |
| Normorphine (9313) |
I |
| Pholcodine (9314) |
I |
| Tilidine (9750) |
I |
| 3-Methylfentanyl (9813) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| Phencyclidine (7471) |
II |
| Phenylacetone (8501) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Oxymorphone (9652) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The company plans to import analytical reference standards for distribution
to its customers for research and analytical purposes.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Lipomed,
Inc. to import the basic classes of controlled substances is consistent with the
public interest and with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA has
investigated Lipomed, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification of the
company's compliance with State and local laws, and a review of the company's
background and history. Therefore, pursuant to 21
U.S.C. 952(a) and 958(a), and
in accordance with 21 CFR
1301.34, the above named company is granted
registration as an importer of the basic classes of controlled substances
listed.
Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-15445 Filed 6-29-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
